BCAT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Increased levels of the BCAT gene, BCAT1 have been extensively reported in malignancies including gliomas [17, 18], ovarian [19], colorectal [20], gastric cancer [21], nasopharyngeal carcinomas [22], breast cancer [23] and chronic myeloid leukemia (CML) [24].